Oncology & Cancer

Impact of recurrence score assay varies with patient age

(HealthDay)—For women with early-stage breast cancer, the impact of receipt of the 21-gene recurrence score (RS) assay varies with patient age, according to a study published online Nov. 23 in the Journal of Clinical Oncology.

Oncology & Cancer

Drug might help breast cancer patients avoid heart damage

Many cancer treatments have a dark side—they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they take a heart drug as a preventive measure during their cancer care.

page 12 from 13